UniProtKB - P35568 (IRS1_HUMAN)
(max 400 entries)x
Your basket is currently empty.
Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)
Protein
Insulin receptor substrate 1
Gene
IRS1
Organism
Homo sapiens (Human)
Status
Functioni
May mediate the control of various cellular processes by insulin. When phosphorylated by the insulin receptor binds specifically to various cellular proteins containing SH2 domains such as phosphatidylinositol 3-kinase p85 subunit or GRB2. Activates phosphatidylinositol 3-kinase when bound to the regulatory p85 subunit (By similarity).By similarity1 Publication
GO - Molecular functioni
- 1-phosphatidylinositol-3-kinase activity Source: Reactome
- insulin-like growth factor receptor binding Source: UniProtKB
- insulin receptor binding Source: UniProtKB
- phosphatidylinositol 3-kinase binding Source: UniProtKB
- phosphatidylinositol-4,5-bisphosphate 3-kinase activity Source: Reactome
- phosphotyrosine binding Source: CAFA
- protein kinase C binding Source: BHF-UCL
- Ras guanyl-nucleotide exchange factor activity Source: Reactome
- SH2 domain binding Source: UniProtKB
- signal transducer activity Source: ProtInc
- transmembrane receptor protein tyrosine kinase adaptor activity Source: BHF-UCL
GO - Biological processi
- cellular response to insulin stimulus Source: BHF-UCL
- glucose homeostasis Source: BHF-UCL
- insulin-like growth factor receptor signaling pathway Source: UniProtKB
- insulin receptor signaling pathway Source: BHF-UCL
- MAPK cascade Source: Reactome
- negative regulation of insulin receptor signaling pathway Source: BHF-UCL
- negative regulation of insulin secretion Source: BHF-UCL
- phosphatidylinositol 3-kinase signaling Source: BHF-UCL
- phosphatidylinositol-mediated signaling Source: Reactome
- positive regulation of cell proliferation Source: BHF-UCL
- positive regulation of fatty acid beta-oxidation Source: BHF-UCL
- positive regulation of glucose import Source: BHF-UCL
- positive regulation of glucose import in response to insulin stimulus Source: BHF-UCL
- positive regulation of glucose metabolic process Source: BHF-UCL
- positive regulation of glycogen biosynthetic process Source: BHF-UCL
- positive regulation of insulin receptor signaling pathway Source: BHF-UCL
- positive regulation of phosphatidylinositol 3-kinase activity Source: BHF-UCL
- regulation of phosphatidylinositol 3-kinase signaling Source: Reactome
- response to insulin Source: BHF-UCL
- response to peptide hormone Source: BHF-UCL
- signal transduction Source: ProtInc
Keywordsi
| Molecular function | Transducer |
Enzyme and pathway databases
| Reactomei | R-HSA-109704. PI3K Cascade. R-HSA-112412. SOS-mediated signalling. R-HSA-1257604. PIP3 activates AKT signaling. R-HSA-198203. PI3K/AKT activation. R-HSA-2219530. Constitutive Signaling by Aberrant PI3K in Cancer. R-HSA-2428928. IRS-related events triggered by IGF1R. R-HSA-2586552. Signaling by Leptin. R-HSA-5673001. RAF/MAP kinase cascade. R-HSA-6811558. PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling. R-HSA-74713. IRS activation. R-HSA-74749. Signal attenuation. R-HSA-982772. Growth hormone receptor signaling. |
| SignaLinki | P35568. |
| SIGNORi | P35568. |
Names & Taxonomyi
| Protein namesi | Recommended name: Insulin receptor substrate 1Short name: IRS-1 |
| Gene namesi | Name:IRS1 |
| Organismi | Homo sapiens (Human) |
| Taxonomic identifieri | 9606 [NCBI] |
| Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
| Proteomesi |
|
Organism-specific databases
| HGNCi | HGNC:6125. IRS1. |
Subcellular locationi
GO - Cellular componenti
- caveola Source: BHF-UCL
- cytoplasm Source: UniProtKB
- cytosol Source: GO_Central
- insulin receptor complex Source: BHF-UCL
- intracellular membrane-bounded organelle Source: UniProtKB
- nucleus Source: UniProtKB
- plasma membrane Source: Reactome
Pathology & Biotechi
Involvement in diseasei
Diabetes mellitus, non-insulin-dependent (NIDDM)3 Publications
The gene represented in this entry may be involved in disease pathogenesis.
Disease descriptionA multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.
See also OMIM:125853| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_005301 | 723 | Missing in NIDDM. 1 Publication | 1 | |
| Natural variantiVAR_005302 | 1043 | S → Y in NIDDM. 1 Publication | 1 | |
| Natural variantiVAR_005303 | 1095 | C → Y in NIDDM. 1 Publication | 1 |
Mutagenesis
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Mutagenesisi | 307 | S → A: Impaired degradation by the Cul7-RING(FBXW8) complex; when associated with A-312; A-527; A-636 and A-639. 1 Publication | 1 | |
| Mutagenesisi | 312 | S → A: Impaired degradation by the Cul7-RING(FBXW8) complex; when associated with A-307; A-527; A-636 and A-639. 1 Publication | 1 | |
| Mutagenesisi | 527 | S → A: Impaired degradation by the Cul7-RING(FBXW8) complex; when associated with A-307; A-312; A-636 and A-639. 1 Publication | 1 | |
| Mutagenesisi | 636 | S → A: Impaired degradation by the Cul7-RING(FBXW8) complex; when associated with A-307; A-312; A-527 and A-639. 1 Publication | 1 | |
| Mutagenesisi | 639 | S → A: Impaired degradation by the Cul7-RING(FBXW8) complex; when associated with A-307; A-312; A-527 and A-636. 1 Publication | 1 | |
| Mutagenesisi | 794 | S → A: Loss of phosphorylation by SIK2. 1 Publication | 1 |
Keywords - Diseasei
Diabetes mellitus, Disease mutationOrganism-specific databases
| DisGeNETi | 3667. |
| MalaCardsi | IRS1. |
| MIMi | 125853. phenotype. |
| OpenTargetsi | ENSG00000169047. |
| PharmGKBi | PA203. |
Chemistry databases
| DrugBanki | DB08513. [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID. |
Polymorphism and mutation databases
| BioMutai | IRS1. |
| DMDMi | 547738. |
PTM / Processingi
Molecule processing
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| ChainiPRO_0000084236 | 1 – 1242 | Insulin receptor substrate 1Add BLAST | 1242 |
Amino acid modifications
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Modified residuei | 3 | PhosphoserineBy similarity | 1 | |
| Modified residuei | 99 | Phosphoserine; by CK2By similarity | 1 | |
| Modified residuei | 270 | Phosphoserine; by RPS6KB11 Publication | 1 | |
| Modified residuei | 307 | Phosphoserine; by RPS6KB12 Publications | 1 | |
| Modified residuei | 312 | Phosphoserine; by IKKB, MAPK8 and RPS6KB12 Publications | 1 | |
| Modified residuei | 323 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 330 | PhosphoserineBy similarity | 1 | |
| Modified residuei | 345 | PhosphoserineBy similarity | 1 | |
| Modified residuei | 348 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 419 | PhosphoserineBy similarity | 1 | |
| Modified residuei | 446 | PhosphothreonineBy similarity | 1 | |
| Modified residuei | 453 | PhosphothreonineCombined sources | 1 | |
| Modified residuei | 465 | Phosphotyrosine; by INSRBy similarity | 1 | |
| Modified residuei | 527 | Phosphoserine; by RPS6KB1Combined sources1 Publication | 1 | |
| Modified residuei | 612 | Phosphotyrosine; by INSR1 Publication | 1 | |
| Modified residuei | 629 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 632 | Phosphotyrosine; by INSR1 Publication | 1 | |
| Modified residuei | 636 | Phosphoserine; by RPS6KB1Combined sources2 Publications | 1 | |
| Modified residuei | 662 | PhosphotyrosineCombined sources | 1 | |
| Modified residuei | 794 | Phosphoserine; by AMPK and SIK21 Publication | 1 | |
| Modified residuei | 892 | PhosphoserineBy similarity | 1 | |
| Modified residuei | 896 | Phosphotyrosine; by INSRBy similarity | 1 | |
| Modified residuei | 941 | Phosphotyrosine; by INSR1 Publication | 1 | |
| Modified residuei | 989 | Phosphotyrosine; by INSRBy similarity | 1 | |
| Modified residuei | 1100 | PhosphoserineBy similarity | 1 | |
| Modified residuei | 1101 | Phosphoserine; by RPS6KB1 and PKC/PRKCQ2 Publications | 1 | |
| Modified residuei | 1179 | Phosphotyrosine; by INSRBy similarity | 1 | |
| Modified residuei | 1229 | Phosphotyrosine; by INSRBy similarity | 1 |
Post-translational modificationi
Serine phosphorylation of IRS1 is a mechanism for insulin resistance. Ser-312 phosphorylation inhibits insulin action through disruption of IRS1 interaction with the insulin receptor (By similarity). Phosphorylation of Tyr-896 is required for GRB2-binding (By similarity). Phosphorylated by ALK. Phosphorylated at Ser-270, Ser-307, Ser-636 and Ser-1101 by RPS6KB1; phosphorylation induces accelerated degradation of IRS1.By similarity4 Publications
Ubiquitinated by the Cul7-RING(FBXW8) complex in a mTOR-dependent manner, leading to its degradation: the Cul7-RING(FBXW8) complex recognizes and binds IRS1 previously phosphorylated by S6 kinase (RPS6KB1 or RPS6KB2).1 Publication
Keywords - PTMi
Phosphoprotein, Ubl conjugationProteomic databases
| EPDi | P35568. |
| MaxQBi | P35568. |
| PaxDbi | P35568. |
| PeptideAtlasi | P35568. |
| PRIDEi | P35568. |
PTM databases
| iPTMneti | P35568. |
| PhosphoSitePlusi | P35568. |
Miscellaneous databases
| PMAP-CutDBi | P35568. |
Expressioni
Gene expression databases
| Bgeei | ENSG00000169047. |
| CleanExi | HS_IRS1. |
| ExpressionAtlasi | P35568. baseline and differential. |
| Genevisiblei | P35568. HS. |
Organism-specific databases
| HPAi | CAB005261. |
Interactioni
Subunit structurei
Interacts with UBTF and PIK3CA (By similarity). Interacts (via phosphorylated YXXM motifs) with PIK3R1 (By similarity). Interacts with ROCK1 and FER (By similarity). Interacts (via PH domain) with PHIP (By similarity). Interacts with GRB2 (By similarity). Interacts with SOCS7. Interacts (via IRS-type PTB domain) with IGF1R and INSR (via the tyrosine-phosphorylated NPXY motif). Interacts with ALK. Interacts with EIF2AK2/PKR (By similarity).By similarity
Binary interactionsi
GO - Molecular functioni
- insulin-like growth factor receptor binding Source: UniProtKB
- insulin receptor binding Source: UniProtKB
- phosphatidylinositol 3-kinase binding Source: UniProtKB
- phosphotyrosine binding Source: CAFA
- protein kinase C binding Source: BHF-UCL
- SH2 domain binding Source: UniProtKB
- transmembrane receptor protein tyrosine kinase adaptor activity Source: BHF-UCL
Protein-protein interaction databases
| BioGridi | 109874. 59 interactors. |
| DIPi | DIP-523N. |
| IntActi | P35568. 26 interactors. |
| MINTi | MINT-149537. |
| STRINGi | 9606.ENSP00000304895. |
Structurei
Secondary structure
Legend: HelixTurnBeta strandPDB Structure known for this area
Show more details| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Beta strandi | 13 – 20 | Combined sources | 8 | |
| Turni | 22 – 24 | Combined sources | 3 | |
| Beta strandi | 27 – 33 | Combined sources | 7 | |
| Turni | 37 – 39 | Combined sources | 3 | |
| Beta strandi | 40 – 49 | Combined sources | 10 | |
| Helixi | 50 – 54 | Combined sources | 5 | |
| Beta strandi | 61 – 65 | Combined sources | 5 | |
| Helixi | 66 – 68 | Combined sources | 3 | |
| Beta strandi | 69 – 75 | Combined sources | 7 | |
| Beta strandi | 81 – 90 | Combined sources | 10 | |
| Beta strandi | 92 – 96 | Combined sources | 5 | |
| Helixi | 100 – 113 | Combined sources | 14 | |
| Beta strandi | 161 – 172 | Combined sources | 12 | |
| Helixi | 173 – 176 | Combined sources | 4 | |
| Beta strandi | 181 – 187 | Combined sources | 7 | |
| Beta strandi | 189 – 196 | Combined sources | 8 | |
| Beta strandi | 203 – 207 | Combined sources | 5 | |
| Helixi | 208 – 210 | Combined sources | 3 | |
| Beta strandi | 211 – 217 | Combined sources | 7 | |
| Beta strandi | 220 – 225 | Combined sources | 6 | |
| Beta strandi | 233 – 239 | Combined sources | 7 | |
| Helixi | 243 – 258 | Combined sources | 16 | |
| Helixi | 259 – 261 | Combined sources | 3 | |
| Beta strandi | 897 – 901 | Combined sources | 5 |
3D structure databases
| Select the link destinations: PDBei RCSB PDBi PDBji Links Updated | PDB entry | Method | Resolution (Å) | Chain | Positions | PDBsum |
| 1IRS | NMR | - | A | 157-267 | [»] | |
| 1K3A | X-ray | 2.10 | B | 891-902 | [»] | |
| 1QQG | X-ray | 2.30 | A/B | 4-267 | [»] | |
| 2Z8C | X-ray | 3.25 | B | 731-736 | [»] | |
| ProteinModelPortali | P35568. | |||||
| SMRi | P35568. | |||||
| ModBasei | Search... | |||||
| MobiDBi | Search... | |||||
Miscellaneous databases
| EvolutionaryTracei | P35568. |
Family & Domainsi
Domains and Repeats
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Domaini | 12 – 115 | PHPROSITE-ProRule annotationAdd BLAST | 104 | |
| Domaini | 160 – 264 | IRS-type PTBPROSITE-ProRule annotationAdd BLAST | 105 |
Region
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Regioni | 3 – 137 | Mediates interaction with PHIPBy similarityAdd BLAST | 135 | |
| Regioni | 896 – 898 | GRB2-bindingBy similarity | 3 |
Motif
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Motifi | 465 – 468 | YXXM motif 1 | 4 | |
| Motifi | 551 – 554 | YXXM motif 2 | 4 | |
| Motifi | 612 – 615 | YXXM motif 3 | 4 | |
| Motifi | 632 – 635 | YXXM motif 4 | 4 | |
| Motifi | 662 – 665 | YXXM motif 5 | 4 | |
| Motifi | 732 – 735 | YXXM motif 6 | 4 | |
| Motifi | 941 – 944 | YXXM motif 7 | 4 | |
| Motifi | 989 – 992 | YXXM motif 8 | 4 | |
| Motifi | 1012 – 1015 | YXXM motif 9 | 4 |
Compositional bias
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Compositional biasi | 128 – 134 | Poly-Gly | 7 | |
| Compositional biasi | 268 – 444 | Ser-richAdd BLAST | 177 | |
| Compositional biasi | 680 – 686 | Poly-Ser | 7 | |
| Compositional biasi | 807 – 815 | Poly-Ser | 9 | |
| Compositional biasi | 877 – 882 | Poly-Gln | 6 | |
| Compositional biasi | 1192 – 1210 | Pro-richAdd BLAST | 19 |
Keywords - Domaini
RepeatPhylogenomic databases
| eggNOGi | ENOG410IXEK. Eukaryota. ENOG410Z9EP. LUCA. |
| GeneTreei | ENSGT00530000063420. |
| HOGENOMi | HOG000113103. |
| HOVERGENi | HBG000542. |
| InParanoidi | P35568. |
| KOi | K16172. |
| OMAi | NGYMMMS. |
| OrthoDBi | EOG091G02EF. |
| PhylomeDBi | P35568. |
| TreeFami | TF325994. |
Family and domain databases
| CDDi | cd01204. PTB_IRS. 1 hit. |
| Gene3Di | 2.30.29.30. 2 hits. |
| InterProi | View protein in InterPro IPR002404. IRS_PTB. IPR011993. PH_dom-like. IPR001849. PH_domain. |
| Pfami | View protein in Pfam PF02174. IRS. 1 hit. PF00169. PH. 1 hit. |
| PRINTSi | PR00628. INSULINRSI. |
| SMARTi | View protein in SMART SM00233. PH. 1 hit. SM00310. PTBI. 1 hit. |
| SUPFAMi | SSF50729. SSF50729. 2 hits. |
| PROSITEi | View protein in PROSITE PS51064. IRS_PTB. 1 hit. PS50003. PH_DOMAIN. 1 hit. |
Sequencei
Sequence statusi: Complete.
P35568-1 [UniParc]FASTAAdd to basket
10 20 30 40 50
MASPPESDGF SDVRKVGYLR KPKSMHKRFF VLRAASEAGG PARLEYYENE
60 70 80 90 100
KKWRHKSSAP KRSIPLESCF NINKRADSKN KHLVALYTRD EHFAIAADSE
110 120 130 140 150
AEQDSWYQAL LQLHNRAKGH HDGAAALGAG GGGGSCSGSS GLGEAGEDLS
160 170 180 190 200
YGDVPPGPAF KEVWQVILKP KGLGQTKNLI GIYRLCLTSK TISFVKLNSE
210 220 230 240 250
AAAVVLQLMN IRRCGHSENF FFIEVGRSAV TGPGEFWMQV DDSVVAQNMH
260 270 280 290 300
ETILEAMRAM SDEFRPRSKS QSSSNCSNPI SVPLRRHHLN NPPPSQVGLT
310 320 330 340 350
RRSRTESITA TSPASMVGGK PGSFRVRASS DGEGTMSRPA SVDGSPVSPS
360 370 380 390 400
TNRTHAHRHR GSARLHPPLN HSRSIPMPAS RCSPSATSPV SLSSSSTSGH
410 420 430 440 450
GSTSDCLFPR RSSASVSGSP SDGGFISSDE YGSSPCDFRS SFRSVTPDSL
460 470 480 490 500
GHTPPARGEE ELSNYICMGG KGPSTLTAPN GHYILSRGGN GHRCTPGTGL
510 520 530 540 550
GTSPALAGDE AASAADLDNR FRKRTHSAGT SPTITHQKTP SQSSVASIEE
560 570 580 590 600
YTEMMPAYPP GGGSGGRLPG HRHSAFVPTR SYPEEGLEMH PLERRGGHHR
610 620 630 640 650
PDSSTLHTDD GYMPMSPGVA PVPSGRKGSG DYMPMSPKSV SAPQQIINPI
660 670 680 690 700
RRHPQRVDPN GYMMMSPSGG CSPDIGGGPS SSSSSSNAVP SGTSYGKLWT
710 720 730 740 750
NGVGGHHSHV LPHPKPPVES SGGKLLPCTG DYMNMSPVGD SNTSSPSDCY
760 770 780 790 800
YGPEDPQHKP VLSYYSLPRS FKHTQRPGEP EEGARHQHLR LSTSSGRLLY
810 820 830 840 850
AATADDSSSS TSSDSLGGGY CGARLEPSLP HPHHQVLQPH LPRKVDTAAQ
860 870 880 890 900
TNSRLARPTR LSLGDPKAST LPRAREQQQQ QQPLLHPPEP KSPGEYVNIE
910 920 930 940 950
FGSDQSGYLS GPVAFHSSPS VRCPSQLQPA PREEETGTEE YMKMDLGPGR
960 970 980 990 1000
RAAWQESTGV EMGRLGPAPP GAASICRPTR AVPSSRGDYM TMQMSCPRQS
1010 1020 1030 1040 1050
YVDTSPAAPV SYADMRTGIA AEEVSLPRAT MAAASSSSAA SASPTGPQGA
1060 1070 1080 1090 1100
AELAAHSSLL GGPQGPGGMS AFTRVNLSPN RNQSAKVIRA DPQGCRRRHS
1110 1120 1130 1140 1150
SETFSSTPSA TRVGNTVPFG AGAAVGGGGG SSSSSEDVKR HSSASFENVW
1160 1170 1180 1190 1200
LRPGELGGAP KEPAKLCGAA GGLENGLNYI DLDLVKDFKQ CPQECTPEPQ
1210 1220 1230 1240
PPPPPPPHQP LGSGESSSTR RSSEDLSAYA SISFQKQPED RQ
Experimental Info
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Sequence conflicti | 134 | G → GG in AAB21608 (PubMed:1311924).Curated | 1 | |
| Sequence conflicti | 362 | S → R in AAB21608 (PubMed:1311924).Curated | 1 | |
| Sequence conflicti | 384 | P → R in AAB21608 (PubMed:1311924).Curated | 1 |
Polymorphismi
The Arg-971 polymorphism impairs the ability of insulin to stimulate glucose transport, glucose transporter translocation, and glycogen synthesis by affecting the PI3K/AKT1/GSK3 signaling pathway. The polymorphism at Arg-971 may contribute to the in vivo insulin resistance observed in carriers of this variant. Arg-971 could contribute to the risk for atherosclerotic cardiovascular diseases associated with non-insulin-dependent diabetes mellitus (NIDDM) by producing a cluster of insulin resistance-related metabolic abnormalities. In insulin-stimulated human endothelial cells from carriers of the Arg-971 polymorphism, genetic impairment of the IRS1/PI3K/PDPK1/AKT1 insulin signaling cascade results in impaired insulin-stimulated nitric oxide (NO) release and suggested that this may be a mechanism through which the Arg-971 polymorphism contributes to the genetic predisposition to develop endothelial dysfunction and cardiovascular disease. The Arg-971 polymorphism not only reduces phosphorylation of the substrate but allows IRS1 to act as an inhibitor of PI3K, producing global insulin resistance.
Natural variant
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_014853 | 158 | P → R. Corresponds to variant dbSNP:rs1801108Ensembl. | 1 | |
| Natural variantiVAR_014854 | 209 | M → T. Corresponds to variant dbSNP:rs1801118Ensembl. | 1 | |
| Natural variantiVAR_005299 | 512 | A → P1 PublicationCorresponds to variant dbSNP:rs1801276Ensembl. | 1 | |
| Natural variantiVAR_025320 | 608 | T → R May contribute to insulin resistance by impairing metabolic signaling through PI3K-dependent pathways. 1 PublicationCorresponds to variant dbSNP:rs104893642Ensembl. | 1 | |
| Natural variantiVAR_005301 | 723 | Missing in NIDDM. 1 Publication | 1 | |
| Natural variantiVAR_014855 | 809 | S → F. Corresponds to variant dbSNP:rs1801120Ensembl. | 1 | |
| Natural variantiVAR_014856 | 892 | S → G. Corresponds to variant dbSNP:rs1801277Ensembl. | 1 | |
| Natural variantiVAR_005300 | 971 | G → R5 PublicationsCorresponds to variant dbSNP:rs1801278Ensembl. | 1 | |
| Natural variantiVAR_005302 | 1043 | S → Y in NIDDM. 1 Publication | 1 | |
| Natural variantiVAR_005303 | 1095 | C → Y in NIDDM. 1 Publication | 1 | |
| Natural variantiVAR_021837 | 1137 | D → N. Corresponds to variant dbSNP:rs3731594Ensembl. | 1 |
Sequence databases
| Select the link destinations: EMBLi GenBanki DDBJi Links Updated | S85963 Genomic DNA. Translation: AAB21608.1. S62539 mRNA. Translation: AAB27175.1. BC053895 mRNA. Translation: AAH53895.1. |
| CCDSi | CCDS2463.1. |
| PIRi | I53160. JS0670. |
| RefSeqi | NP_005535.1. NM_005544.2. |
| UniGenei | Hs.471508. |
Genome annotation databases
| Ensembli | ENST00000305123; ENSP00000304895; ENSG00000169047. |
| GeneIDi | 3667. |
| KEGGi | hsa:3667. |
| UCSCi | uc002voh.5. human. |
Keywords - Coding sequence diversityi
PolymorphismSimilar proteinsi
Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:| 100% | UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into one UniRef entry. |
| 90% | UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence). |
| 50% | UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster. |
Entry informationi
| Entry namei | IRS1_HUMAN | |
| Accessioni | P35568Primary (citable) accession number: P35568 | |
| Entry historyi | Integrated into UniProtKB/Swiss-Prot: | June 1, 1994 |
| Last sequence update: | June 1, 1994 | |
| Last modified: | June 7, 2017 | |
| This is version 190 of the entry and version 1 of the sequence. See complete history. | ||
| Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
| Annotation program | Chordata Protein Annotation Program | |
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | |
Miscellaneousi
Keywords - Technical termi
3D-structure, Complete proteome, Reference proteomeDocuments
- Human chromosome 2
Human chromosome 2: entries, gene names and cross-references to MIM - Human entries with polymorphisms or disease mutations
List of human entries with polymorphisms or disease mutations - Human polymorphisms and disease mutations
Index of human polymorphisms and disease mutations - MIM cross-references
Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot - PDB cross-references
Index of Protein Data Bank (PDB) cross-references
